Grateziano (Sofosbuvir 400 mg) – is a drug for the treatment of hepatitis C
Grateziano – is a medicinal product for the integrated interferon-free treatment of hepatitis C, which contains the substance sofosbuvir in an amount of 400 mg.
The drug is resolved by the Ministry of Healthcare of Ukraine and included in the state register of medicines. In addition, the Federal Food and Drug Administration of the USA approves the active ingredient of the drug for use in combination with ribavirin as interferon-free treatment of hepatitis C genotype 2 and 3. The World Health Organization (WHO) introduces Sofosbuvir in the essential drugs list.
Medicinal product Grateziano – is a generic of Egypt’s sofosbuvir production, which can be bought in Ukraine officially.
1 tablet is coated and contains 400 mg of sofosbuvir
Direct-acting antiviral drug. Code number АТХ J05A X15.
Grateziano is used in combination with other drugs for the treatment of chronic hepatitis C virus (CHC) infection in adults.
Hypersensitivity to active agent or to any of the components of the drug.
Dosage and administration
Grateziano must be used only under the supervision of a physician who has experience in treatment of patients with Chronic hepatitis C (CHC).
The recommended dose is one 400 mg tablet, taken orally, once daily with food
Grateziano should be used in combination with other drugs. Grateziano must not be administered as monotherapy.
Safety and effectiveness in children (at age of <18) are not determined
Category of delivery
You can buy Grateziano (sofosbuvir 400 mg) in pharmacies of Ukraine; the drug is a prescription only medicine.
- The only generic sofosbuvir registered on the territory of Ukraine.
- Therapeutic and pharmaceutical equivalence is proved.
- There is no need for dose adjustment even in severely impaired liver function.
- Comfortable storage temperature requirements – up to 30° C
- Reasonable price.
1.Certificate of GMP compliance of a manufacturer №029/2015/RO issued by PIC/S on 11/08/2015
2. Conclusion on the confirmation of conformity of production of medicines, the requirements ofGood Manufacturing Practice (GMP) №0373 / 2015 / SAUMP / C-797 issued by the StateService of Ukraine on drugs from 10.09.2015.
3.Instruction for medical use of product “Grateziano”; MA №UA / 14761/01/01; Order of theMinistry of Health of Ukraine dated 18.11.2015 №753